Nerve growth factor inhibitor with novel-binding domain demonstrates nanomolar efficacy in both cell-based and cell-free assay systems
作者:Allison E. Kennedy、Corey A. Laamanen、Mitchell S. Ross、Rahul Vohra、Douglas R. Boreham、John A. Scott、Gregory M. Ross
DOI:10.1002/prp2.339
日期:2017.10
Nervegrowthfactor (NGF), a member of the neurotrophin family, is known to regulate the development and survival of a select population of neurons through the binding and activation of the TrkA receptor. Elevated levels of NGF have been associated with painful pathologies such as diabetic neuropathy and fibromyalgia. However, completely inhibiting the NGF signal could hold significant side effects